Indications and uses
RevivaSil™ Gel-Pad Kit is intended for managing hypertrophic, hyperpigmented, and keloid scar tissue.
RevivaSil™ Gel-Pad Kit is intended for managing hypertrophic, hyperpigmented, and keloid scar tissue.
1) Wash your hands and the scar area with soap and water. Dry thoroughly. 2) Cut the RevivaSil™ Gel-Pad to fit the scar area as needed, so that the edges extend at least 1/4" beyond the scar on all sides. 3) Gently peel the gel-pad from the Mylar release strip (it is normal for small bits of the gel to remain on the Mylar release strip). Do not discard the Mylar release strip. 4) Place the sticky side of the gel-p...
RevivaSil™ Gel-Pad Kit is intended for managing hypertrophic, hyperpigmented, and keloid scar tissue.
Non-sterile product is labeled as such and supplied in protective packaging and container.
Rashes may occur on skin under gel-pad due to poor hygiene. Rashes may also result from wrapping gel-pad too tightly around skin. Stop use and ask a doctor if gel-pad is applied properly and skin irritation still occurs.
Discoloration of skin covered by gel-pad may temporarily occur in patients with darker complexions.
Do not use creams, lotions, sun block, or other silicone products on your skin when wearing gel-pad. Only apply gel-pad to clean, bare skin.
Do not apply to open wounds or third degree burns. Never use on a sutured wound until sutures have been removed or when any dermatological conditions disrupt the skin (such as a rash or burn). In rare instances, silicone sheets may cause a rash on the skin. This condition may result from improper cleansing of the scar area where the gel-pad has been applied. Stop use and ask a doctor if product is applied properly and skin irritation still occurs. Persons with dermatological disorders should contact their doctor prior to using this product.
* Proper use, and gentle care of the gel-pad will be re-usable up to eight (8) days.
PRODUCT FACTS
| Active Component | Purpose |
|---|---|
| Patented Silicone Gel Matrix Pad | Skin Scar Treatment |
Silicone Gel Matrix Pad (3'' X 5.5'')
Engineered as a self-adhesive pad; there is no need for additional wraps or taping. The non-sticky side is smooth and soft to prevent fabrics from adhering.
Do not apply to open wounds or third degree burns. Never use on a sutured wound until sutures have been removed or when any dermatological conditions disrupt the skin (such as a rash or burn). In rare instances, silicone sheets may cause a rash on the skin. This condition may result from improper cleansing of the scar area where the gel-pad has been applied. Stop use and ask a doctor if product is applied properly and skin irritation still occurs. Persons with dermatological disorders should contact their doctor prior to using this product.
TRIFLUENT
PHARMA®
RevivaSil™
GEL-PAD KIT
QUESTIONS OR COMMENTS:
CALL (210) 944-6920
MANUFACTURED FOR:
Trifluent Pharma, LLC
San Antonio, TX 78213
MADE IN THE U.S.A.
540-01 REV02 12-22-2023
CONTAINS:
FOUR (4) SILICONE GEL-PADS (3" X 5.5") (NON-STERILE)
ONE (1) REVIVA-E™ SOLUTION – 0.5 FL. OZ. (15 mL)
PRODUCT SHOULD BE ADMINISTERED UNDER THE
SUPERVISION OF A LICENSED MEDICAL PRACTITIONER
(CONTENTS NOT FOR INDIVIDUAL SALE OR DISTRIBUTION)
NDC 73352-540-01

| Class | Version | Type | Effective |
|---|---|---|---|
| DIMETHICONE Pharmacologic Class Indexing | 3 | Indexing - Pharmacologic Class | 20180813 |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 73352-540-01 | Reviva-Sil | 1 in 1 BOX | KIT | 1 | 2 |
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 73352-540-01 | EA - Each | 73352-540 | d089a71f-3a9c-4b70-84c5-d946b5ff29ef | 1 | 2024-03-12 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 73352-540 | 73352-540-01 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| DIMETHICONE | 92RU3N3Y1O | ACTIB |
| DIMETHICONE 100 | RO266O364U | IACT |
| CYCLOMETHICONE 5 | 0THT5PCI0R | IACT |
| CYCLOMETHICONE 4 | CZ227117JE | IACT |
| DIMETHICONOL (40 CST) | 343C7U75XW | IACT |
| TOCOPHEROL | R0ZB2556P8 | IACT |
| BUTYLENE GLYCOL | 3XUS85K0RA | IACT |
| PROPYLENE GLYCOL | 6DC9Q167V3 | IACT |
| Version | Effective date | Source | Hydrated |
|---|---|---|---|
| 1 | 2024-02-07 | full-release | 2026-06-01 02:51:01 |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Adverse event summaries are temporarily unavailable. Other product information remains available.